Evaluation of VAL-083, either alone or in combination with other agents, for its activity inhibition of glioblastoma subtypes (personalized drug development)
Research Grant
Administered By
Anesthesiology
Awarded By
DelMar Pharmaceuticals, Inc.
Start Date
April 14, 2017
End Date
April 30, 2020
Administered By
Anesthesiology
Awarded By
DelMar Pharmaceuticals, Inc.
Start Date
April 14, 2017
End Date
April 30, 2020